Cerner Integrates NARxCHECK(TM) Into Electronic Health Record System

Loading...
Loading...

LOUISVILLE, Ky., Aug. 6, 2015 (GLOBE NEWSWIRE) -- Appriss Inc., a leading technology provider for risk assessment and analytics in public safety and health care, announced that Cerner CERN, a global leader in health care techonology, has integrated NARxCHECK into its electronic health record (EHR) system in an effort to fight prescription drug abuse and diversion nationwide.

"We are pleased to announce the Cerner integration as the first national EHR integration of NARxCHECK," said Mike Davis, CEO of Appriss, Inc. "The epidemic of prescription abuse and diversion continues to grow. Providing actionable analytics of a patient's prescription history inside a physician's workflow could save lives."

NARXCHECK Logo


NARxCHECK (http://www.appriss.com/narxcheck.html), is an analytics solution that provides near real-time insights directly in the EHR to assist clinicians in making better prescribing decisions for controlled substances. The program provides three key components for prescribers and dispensers: a patient score, an interactive graph detailing the prescribing patterns and detailed information about each prescription. An algorithm assesses and computes the history from a prescriptions-dispensed database, including statewide prescription drug monitoring programs (PDMP), to highlight potential abuse of narcotics, sedatives and stimulants.

Embedding NARxCHECK within the Cerner EHR gives prescribers near real-time access to PDMP data and provides transparency to states to monitor compliance. Cerner is the only EHR supplier to package this process with one simple deployment.

"Through the integration of NARxCHECK directly within the Cerner EHR, we are one step closer to breaking down interoperability barriers across health care," said Bob Robke, vice president of interoperability at Cerner. "Providers will now have access to powerful PDMP data in seconds, a task that until now has added time and complexity to their workflow."

About Appriss

Appriss provides data-driven solutions to fulfill our mission of keeping communities safe and informed.  Partnering with public safety, healthcare, and leading private and public companies, Appriss delivers solutions that prevent fraud, mitigate risk, fight crime, ensure compliance, increase public safety and save lives.  Appriss' solutions are always backed by excellent customer support with technical agents in the U.S. that are available to help 24x7x365.

For more information, visit www.appriss.com (http://www.appriss.com).

About Cerner

Cerner's health information technologies connect people, information and systems, at more than 18,000 facilities worldwide. Recognized for innovation, Cerner solutions assist clinicians in making care decisions and enable organizations to manage the health of populations. The company also offers an integrated clinical and financial system to help health care organizations manage revenue, as well as a wide range of services to support clients' clinical, financial and operational needs. Cerner's mission is to contribute to the systemic improvement of health care delivery and the health of communities. On February 2, 2015, Cerner Corporation acquired substantially all of the assets, and assumed certain liabilities, of the Siemens Health Services business from Siemens AG. Nasdaq: CERN. For more information about Cerner, visit www.cerner.com, read our blog at www.cerner.com/blog, connect with us on Twitter at http://www.twitter.com/cerner and on Facebook at www.facebook.com/cerner.

Certain trademarks, service marks and logos set forth herein are property of Cerner Corporation and/or its subsidiaries. All other non-Cerner marks are the property of their respective owners.

CONTACT: Appriss Kathy Sue Bennett, ksuebennett@appriss.com Cerner Victoria Guerra, victoria.guerra@cerner.com

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: Press Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...